In vivo, 131I SPECT imaging revealed a clear image of the tumor xenografts, and therapeutic experiments with 131I in baculovirus-infected tumors further confirmed the potential of this new strategy of NIS-mediated gene therapy accompanied by K5-based antiangiogenic therapy. This evidence concerns the gene SLC5A5 and neoplasm.